PT-141 (Bremelanotide) vials typically come in 10 mg sizes. For subcutaneous research, reconstitute with 2 ml bacteriostatic water to get a 5 mg/ml concentration. That means 0.1 ml from your insulin syringe delivers 0.5 mg.
Subcutaneous PT-141 Dosing Protocol
Inject PT-141 subcutaneously into belly fat or thigh, using a 29-31 gauge insulin syringe. Start low to gauge your response.
- Week 1: 0.5 mg (0.1 ml) once, wait 72 hours, repeat if no issues.
- Week 2: Increase to 1 mg (0.2 ml), same 72-hour gap.
- Maintenance: 1.5 to 2 mg (0.3 to 0.4 ml) per dose, no more than twice weekly.
Run the total cycle for 4 to 8 weeks, then take 4 weeks off. Effects last 24 to 72 hours, so space doses to avoid tolerance. Track arousal response starting 30 to 60 minutes after injection; it peaks around 2 hours.
Use our PT-141 calculator to dial in exact volumes for your vial concentration.
Nasal Spray PT-141 Protocol
Nasal PT-141 skips needles. Mix 10 mg powder with 10 ml bacteriostatic water or saline for a 1 mg/ml spray. Each 0.1 ml squirt (one spray per nostril) delivers 0.1 mg, but absorption varies between 30 and 50%.
- Starting dose: 0.5 to 1 mg (5 to 10 sprays, 2-3 per nostril).
- Full dose: 1.5 to 2 mg (15 to 20 sprays).
- Timing: Alternate nostrils, 10 minutes apart if stacking sprays. Onset is 10 to 30 minutes, with a shorter duration than subQ (6 to 12 hours).
Nasal works faster for acute research, but expect 20 to 30% less potency. Store the spray bottle in the fridge and shake before use. Limit to 3 days weekly.
Reconstitution Steps for PT-141
- Wipe the vial top with alcohol.
- Draw 2 ml bacteriostatic water into a syringe.
- Slowly drip water down the vial side—don't blast the powder.
- Let it sit for 10 minutes, then gently roll to dissolve. Avoid shaking.
- Aliquot into sterile vials if not using immediately.
For a 10 mg vial with 2 ml, you get 5 mg/ml. Refrigerate at 2 to 8 C. Use within 28 days. Discard if cloudy.
For nasal: Use the same process, but with 10 ml for a 1 mg/ml solution in a nasal bottle with a 0.1 ml actuator.
Timing Your PT-141 Doses
Dose 2 to 4 hours before you want effects. For subQ: Inject in the evening for an overnight research window. For nasal: Anytime, but avoid food 30 minutes prior for better uptake.
- Onset: SubQ 30-60 min; Nasal 10-30 min.
- Peak: 1-3 hours.
- Duration: SubQ 24-72 hours; Nasal 6-12 hours.
- Frequency: Every 72 hours minimum. Max 2 doses/week.
Pair with hydration—drink 500 ml water before dosing to reduce nausea risk.
PT-141 Side Effects Research
You'll likely experience facial flushing 15-45 minutes after dosing, lasting 1-2 hours. Nausea occurs in 20 to 30% of doses at 1 mg or higher; take an antiemetic 30 minutes prior if you're prone to it.
Other notes:
- Headaches: Take 500 mg ibuprofen at onset.
- Spontaneous arousal: Peaks around hour 2, manageable.
- Injection site: Rare itch, rotate spots.
- Blood pressure: Monitor if hypertensive; it rises 10-20 mmHg temporarily.
Tolerance builds after 4-6 doses—cycle off. No long-term data exists beyond 12 weeks.
Storage and Stability
Lyophilized PT-141 is stable at room temperature (under 25 C) for 2 years. Once reconstituted: store in the fridge at 2-8 C, maximum 30 days. Do not freeze—it can crystallize.
For travel: Keep powder dry in a cooler. Nasal spray: Store upright with a tight cap.
Stacking PT-141 with Other Peptides
Combine for synergy in sexual peptide research.
- With CJC-1295/Ipamorelin: 100 mcg each nightly boosts libido baseline. CJC-1295/Ipamorelin calculator.
- BPC-157: 250 mcg twice daily reduces gut side effects. BPC-157 calculator.
- GHK-Cu: 1 mg subQ daily for skin/vascular support. GHK-Cu calculator.
Avoid stacking with stimulants—they can amplify blood pressure spikes.
Advanced Protocols
Loading phase: 0.5 mg daily for 3 days, then 1.5 mg twice weekly. For rapid response.
Microdosing nasal: 0.2 mg (2 sprays) daily for steady effects and low sides.
Women-specific: Start at 0.25 mg subQ; arousal patterns differ, with less flushing.
Women report genital sensitivity starting 45 minutes in, lasting up to 48 hours.
Comparison: SubQ vs Nasal PT-141
| Aspect | Subcutaneous | Nasal Spray |
|---|---|---|
| Dose accuracy | High (95%+) | Variable (50-80%) |
| Onset | 30-60 min | 10-30 min |
| Duration | 24-72 hrs | 6-12 hrs |
| Sides intensity | Moderate | Milder |
| Cost per dose | Lower | Higher volume |
Use subQ for precision; nasal for convenience.
Monitoring Progress
Log:
- Dose and time
- Onset and peak intensity (1-10 scale)
- Side effect duration
- Refractory period changes
Adjust up by 0.25 mg increments if your response is under 5/10.
Troubleshooting Common Issues
No effects: Double-check your reconstitution math. Try subQ over nasal. Wait the full 60 minutes.
Too much nausea: Drop to 0.25 mg, sip ginger tea, or pre-dose with Zofran 4 mg.
Flushing allergy? Benadryl 25 mg prevents it in about 80% of cases.
Short duration: Switch to subQ; nasal bioavailability drops with congestion.
This guide covers actionable PT-141 protocols. Scale doses to your vial size using the PT-141 calculator.
Disclaimer: This information is for research purposes only. Consult a healthcare professional before using any peptides. Individual responses vary.